Effect of SR-49059, a vasopressin V1a antagonist, on human vascular smooth muscle cells
C. Serradeil‐Le Gal(Sanofi (France)), G. Le Fur(Sanofi (France)), Paul Schaeffer(Universidad La Salle), J.P. Maffrand(Sanofi (France)), Danielle Raufaste(Sanofi (France)), E. Marty(Sanofi (France)), Corine Garcia(Sanofi (France)), Jean‐Marc Herbert(Sanofi (France)), F. Dol(Sanofi (France)), Chantal Delisée(Sanofi (France))
American Journal of Physiology-Heart and Circulatory Physiology
January 1, 1995
Cited by 53
Related Papers
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
|Nature Medicine|2001|1.7k
PGC-1α Deficiency Causes Multi-System Energy Metabolic Derangements: Muscle Dysfunction, Abnormal Weight Control and Hepatic Steatosis
|PLoS Biology|2005|943
PGC-1α Coactivates PDK4 Gene Expression via the Orphan Nuclear Receptor ERRα: a Mechanism for Transcriptional Control of Muscle Glucose Metabolism
|Molecular and Cellular Biology|2005|355